[Gly14]-humanin rescues long-term potentiation from amyloid β protein-induced impairment in the rat hippocampal CA1 region in vivo

Synapse

Volumn 64, Issue 1, 2010, Pages 83-91

  Guo, Fen ^a   Jing, Wei ^a   Ma, Cun Gen ^b   Wu, Mei Na ^a   Zhang, Jun Fang ^a   Li, Xin Yi ^a   Qi, Jin Shun ^a,b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHANXI DATONG UNIVERSITY   (China)

Author keywords

A 25 35; Alzheimer's disease; fEPSPs; Paired pulse facilitation

Indexed keywords

[GLYCINE 14] HUMANIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; GENISTEIN; HUMANIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LONG-TERM POTENTIATION; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 72449206626     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20707     Document Type: Article

References (46)

1. Blanchard BJ, Konopka G, Russell M, Ingram VM. 1997. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: Relation to Alzheimer's disease. Brain Res 776:40-50. (Pubitemid 28018456)
2. Bliss TV, Lomo T. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331-356.
3. Chen QS, Kagan BL, Hirakura Y, Xie CW. 2000. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60:65-72. (Pubitemid 30176750)
4. Chiu CY, Chen SH, Wang SH. 2007. Effect of ultrasound doses on the amyloid-Beta 25-35 induced PC12 apoptosis. Conf Proc IEEE Eng Med Biol Soc 1:5837-5840.
5. Choi MM, Kim EA, Hahn HG, Nam KD, Yang SJ, Choi SY, Kim TU, Cho SW, Huh JW. 2007. Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 239:156-166.
6. Debanne D, Guerineau NC, Gahwiler BH, Thompson SM. 1996. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: Quantal fluctuation affects subsequent release. J Physiol 491(Part 1):163-176. (Pubitemid 26059557)
7. Deshpande A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26:6011-6018. (Pubitemid 44318367)
8. Egashira N, Iwasaki K, Akiyoshi Y, Takagaki Y, Hatip-Al-Khatib I, Mishima K, Kurauchi K, Ikeda T, Fujiwara M. 2005. Protective effect of Toki-shakuyaku-san on amyloid β25-35-induced neuronal damage in cultured rat cortical neurons. Phytother Res 19:450-453. (Pubitemid 41285016)
9. Freir DB, Herron CE. 2003. Inhibition of L-type voltage dependent calcium channels causes impairment of long-term potentiation in the hippocampal CA1 region in vivo. Brain Res 967:27-36.
10. Freir DB, Holscher C, Herron CE. 2001. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol 85:708-713. (Pubitemid 32147772)
11. Freir DB, Costello DA, Herron CE. 2003. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J Neurophysiol 89:3061-3069.
12. Hashimoto Y, Ito Y, Niikura T, Shao Z, Hata M, Oyama F, Nishimoto I. 2001a. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun 283:460-468. (Pubitemid 32924714)
13. Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, Abe Y, Kita Y, Nishimoto I. 2001b. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci 21:9235-9245. (Pubitemid 33096867)
14. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I. 2001c. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA 98:6336-6341.
15. Ji X, Naistat D, Li C, Orbulesco J, Leblanc RM. 2006. An alternative approach to amyloid fibrils morphology: CdSe/ZnS quantum dots labelled beta-amyloid peptide fragments Aβ (31-35). Aβ (1-40) and Aβ (1-42). Colloids Surf B Biointerfaces 50:104-111.
16. Kanski J, Varadarajan S, Aksenova M, Butterfield DA. 2002. Role of glycine-33 and methionine-35 in Alzheimer's amyloid β-peptide 1-42-associated oxidative stress and neurotoxicity. Biochim Biophys Acta 1586:190-198. (Pubitemid 34311834)
17. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S. 2002. Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 13:903-907. (Pubitemid 34492924)
18. Krejcova G, Patocka J, Slaninova J. 2004. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 10:636-639. (Pubitemid 39409623)
19. Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao JL, Murphy PM, Oppenheim JJ, Wang JM. 2001. Amyloid (β)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J Neurosci 21:RC123.
20. Mamiya T, Ukai M. 2001. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 134:1597-1599. (Pubitemid 34038091)
21. Martin SJ, Grimwood PD, Morris RG. 2000. Synaptic plasticity and memory: An evaluation of the hypothesis. Annu Rev Neurosci 23:649-711. (Pubitemid 30350057)
22. Micheau J, Riedel G. 1999. Protein kinases: Which one is the memory molecule? Cell Mol Life Sci 55:534-548.
23. Misiti F, Sampaolese B, Pezzotti M, Marini S, Coletta M, Ceccarelli L, Giardina B, Clementi ME. 2005. Aβ(31-35) peptide induce apoptosis in PC 12 cells: Contrast with Aβ(25-35) peptide and examination of underlying mechanisms. Neurochem Int 46:575-583.
24. Misiti F, Clementi ME, Tringali G, Vairano M, Orsini F, Pezzotti M, Navarra P, Giardina B, Pozzoli G. 2006. Fragment 31-35 of β-amyloid peptide induces neurodegeneration in rat cerebellar granule cells via bax gene expression and caspase-3 activation. A crucial role for the redox state of methionine-35 residue. Neurochem Int 49:525-532.
25. Niikura T, Hashimoto Y, Tajima H, Nishimoto I. 2002. Death and survival of neuronal cells exposed to Alzheimer's insults. J Neurosci Res 70:380-391. (Pubitemid 35222377)
26. Niikura T, Tajima H, Kita Y. 2006. Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. Curr Neuropharmacol 4:139-147.
27. Nishimoto I, Matsuoka M, niikura T. 2004. Unravelling the role of Humanin. Trends Mol Med 10:102-105.
28. Qi JS, Qiao JT. 2001a. Amyloid beta-protein fragment 31-35 forms ion channels in membrane patches excised from rat hippocampal neurons. Neuroscience 105:845-852.
29. Qi JS, Qiao JT. 2001b. Suppression of large conductance Ca2+-activated K+ channels by amyloid beta-protein fragment 31-35 in membrane patches excised from hippocampal neurons. Sheng Li Xue Bao 53:198-204. (Pubitemid 33653190)
30. Selkoe DJ. 1998. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453. (Pubitemid 28529718)
31. Shastry BS, Giblin FJ. 1999. Genes and susceptible loci of Alzheimer's disease. Brain Res Bull 48:121-127.
32. Stepanichev MY, Moiseeva YV, Lazareva NA, Gulyaeva NV. 2005. Studies of the effects of fragment (25-35) of β-amyloid peptide on the behavior of rats in a radial maze. Neurosci Behav Physiol 35:511-518.
33. Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, Terashita K, Yamazaki K, Koto A, Aiso S, Nishimoto I. 2002. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett 324:227-231. (Pubitemid 34493875)
34. Tajima H, Kawasumi M, Chiba T, Yamada M, Yamashita K, Nawa M, Kita Y, Kouyama K, Aiso S, Matsuoka M, Niikura T, Nishimoto I. 2005. A humanin derivative. S14G-HN, prevents amyloidβ-induced memory impairment in mice. J Neurosci Res 79:714-723. (Pubitemid 40476451)
35. Takeda S, Watanabe T, Suzuki T. 1997. Metabolism of Alzheimer's amyloid precursor protein. Tanpakushitsu Kakusan Koso 42:1859-1865.
36. Terashita K, Hashimoto Y, Niikura T, Tajima H, Yamagishi Y, Ishizaka M, Kawasumi M, Chiba T, Kanekura K, Yamada M, Nawa M, Kita Y, Aiso S, Nishimoto I. 2003. Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: Functional potentiation by isomerization and dimerization. J Neurochem 85:1521-1538. (Pubitemid 36702564)
37. Varadarajan S, Yatin S, Kanski J, Jahanshahi F, Butterfield DA. 1999. Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress. Brain Res Bull 50:133-141. (Pubitemid 29467333)
38. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539. (Pubitemid 34288854)
39. Yamagishi Y, Hashimoto Y, Niikura T, Nishimoto I. 2003. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults. Peptides 24:585-595. (Pubitemid 36829348)
40. Yan XZ, Qiao JT, Dou Y, Qiao ZD. 1999. β-amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons. Neuroscience 92:177-184. (Pubitemid 29249028)
41. Yang EB, Zhang K, Cheng LY, Mack P. 1998. Butein, a specific protein tyrosine kinase inhibitor. Biochem Biophys Res Commun 245:435-438. (Pubitemid 28418520)
42. Ye L, Qiao JT. 1999. Suppressive action produced by β-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: It's offset by (-)huperzine A. Neurosci Lett 275:187-190. (Pubitemid 29507538)
43. Ying G, Iribarren P, Zhou Y, Gong W, Zhang N, Yu ZX, Le Y, Cui Y, Wang JM. 2004. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 172:7078-7085. (Pubitemid 38669150)
44. Zhang JM, Wu MN, Qi JS, Qiao JT. 2006. Amyloid β-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo. Synapse 60:307-313.
45. Zhang L, Rubinow DR, Xaing G, Li BS, Chang YH, Maric D, Barker JL, Ma W. 2001. Estrogen protects against β-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12:1919-1923. (Pubitemid 32553708)
46. Zhao L, Qian ZM, Zhang C, Wing HY, Du F, Ya K. 2008. Amyloid β-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation. Aging Cell 7:47-57.